Made-In-Singapore Cancer Drug Advances To Clinical Trials
July 20, 2015 | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial. Asian Scientist Magazine
July 20, 2015 | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial. Asian Scientist Magazine
